Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
11,172,782
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
2,187,317
-
Shares change
-
-328,228
-
Total reported value, excl. options
-
$31,168,844
-
Value change
-
-$4,415,868
-
Put/Call ratio
-
35%
-
Number of buys
-
23
-
Number of sells
-
-8
-
Price
-
$14.25
Significant Holders of MediWound Ltd. - COMMON STOCK (MDWD) as of Q1 2024
36 filings reported holding MDWD - MediWound Ltd. - COMMON STOCK as of Q1 2024.
MediWound Ltd. - COMMON STOCK (MDWD) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,187,317 shares
of 11,172,782 outstanding shares and own 20% of the company stock.
Largest 10 shareholders include Rosalind Advisors, Inc. (485,990 shares), Yelin Lapidot Holdings Management Ltd. (287,834 shares), DAFNA Capital Management LLC (188,753 shares), Uniplan Investment Counsel, Inc. (146,110 shares), ESSEX INVESTMENT MANAGEMENT CO LLC (132,487 shares), WELLS FARGO & COMPANY/MN (131,265 shares), Sargent Investment Group, LLC (124,408 shares), Point72 Asset Management, L.P. (121,158 shares), Silverberg Bernstein Capital Management LLC (85,184 shares), and JPMORGAN CHASE & CO (73,337 shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.